[1] Lin C S, Wu T T, Chang C H, et al. Changes of bladder M1,3 muscarinic receptor expression in rats fed with short-term/long-term high-fat diets[J]. Low Urin Tract Symptoms,2017,[Epub ahead of print]. [2] Berndt-Paetz M, Herbst L, Weimann A, et al. Highly specific detection of muscarinic M3 receptor, G protein interaction and intracellular trafficking in human detrusor using Proximity Ligation Assay (PLA)[J].Acta Histochem, 2018,[Epub ahead of print]. [3] Liu Q, Luo D Y, Yang T, et al. Protective effects of antimuscarinics on the bladder remodeling after bladder outlet obstruction[J].Cell Physiol Biochem, 2017, 44(3):907-919. [4] Giglio D, Podmolikova L, Tobin G. Changes in the neuronal control of the urinary bladder in a model of radiation cystitis[J].J Pharmacol Exp Ther, 2018,365(2):327-335. [5] Ehrhardt A, Wang B, Yung A C, et al. Urinary retention, incontinence, and dysregulation of muscarinic receptors in male mice lacking mras[J].PLoS One, 2015, 10(10):e0141493. [6] Wang C T, Chen T M, Mei C T, et al. The functional haplotypes of modulate mRNA expression and associate with bladder cancer among a Chinese han population in kaohsiung city[J].Biomed Res Int, 2016, 2016:4052846. [7] Di Salro J, Nagabukuro H, Wickham L A, et al. Pharmacological characterization of a novel beta 3 adrenergic agonist, vibegron:evaluation of antimuscarinic receptor selectivity for combination therapy for overactive bladder[J].J Pharmacol Exp Ther, 2017, 360(2):346-355. [8] Dong X, Liu A, Zer C, et al. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells[J]. BMC Cancer,2009,9:133. [9] Fowler C J, Griffiths D, de Groat W C. The neural control of micturition[J]. Nat Rev Neurosci, 2008,9(6):453-466. [10] Hannan J L, Powers S A, Wang V M, et al. Impaired contraction and decreased detrusor innervation in a female rat model of pelvic neuropraxia[J]. Int Urogynecol J, 2017,28(7):1049-1056. [11] Hirose H, Aoki I, Kimura T, et al. The subtypes of muscarinic receptors for neurogenic bladder contraction in rats[J]. Eur J Pharmacol, 2002,452(2):245-253. [12] Weber S, Thiele H, Mir S, et al. Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome[J]. Am J Hum Genet, 2011,89(5):668-674. [13] Jositsch G, Papadakis T, Haberberger R V, et al. Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice[J]. Naunyn Schmiedebergs Arch Pharmacol,2009,379(4):389-395. [14] Somogyi G T, de Groat W C. Function, signal transduction mechanisms and plasticity of presynaptic muscarinic receptors in the urinary bladder[J]. Life Sci, 1999,64(6-7):411-418. [15] Igawa Y. Discussion:functional role of M(1), M(2), and M(3) muscarinic receptors in overactive bladder[J]. Urology, 2000,55(5A Suppl):47-49; discussion 50. [16] 房超, 尹晶,于秋爽,等.慢病毒介导的靶向干扰MEX3A基因膀胱癌稳定细胞株的建立[J].首都医科大学学报,2017,38(12):1057-1061,1066. [17] 朱圣韬, 孙秀静, 李鹏,等. PHF8基因对食管鳞状细胞癌裸鼠移植瘤生长的影响[J]. 首都医科大学学报, 2016, 37(1):12-16. [18] 杨洋, 郑军, 徐江,等. Naa10基因RNA干扰慢病毒载体的构建及其对口腔鳞癌细胞生长的影响[J]. 口腔医学研究,2017(7):707-711. [19] 孙达权, 罗福丽, 廖美, 等. HuR基因的慢病毒干扰载体构建及其病毒包装[J]. 贵州医药,2017(6):563-565,673. [20] 莫柒艳, 陈龙, 李龄, 等. 慢病毒介导的靶向干扰PARP-1基因乳腺癌稳定细胞株的构建[J]. 中国癌症防治杂志,2017,9(2):129-133. [21] 程玉霜, 王慧艳, 肖东. 慢病毒介导RNA干扰HES1鼻咽癌稳定细胞株的建立与鉴定[J]. 山东医药, 2017,57(18):9-11. [22] Gagnoux-Palacios L, Hervouet C, Spirito F, et al. Assessment of optimal transduction of primary human skin keratinocytes by viral vectors[J]. J Gene Med, 2005,7(9):1178-1186. [23] Lawson S K, Dobrikova E Y, Shveygert M, et al. p38alpha mitogen-activated protein kinase depletion and repression of signal transduction to translation machinery by miR-124 and-128 in neurons[J]. Mol Cell Biol, 2013,33(1):127-135. [24] Stewart S A, Dykxhoorn D M, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells[J]. RNA, 2003,9(4):493-501. [25] 丰昀. KCTD10基因干扰RNA慢病毒载体的构建[J]. 湖南师范大学学报:医学版,2017,14(2):9-11. |